Literature DB >> 14504362

Biological monitoring of occupational exposure to N,N-dimethylacetamide with identification of a new metabolite.

L Perbellini1, A Princivalle, M Caivano, R Montagnani.   

Abstract

AIMS: To study the concentration of N,N-dimethylacetamide (DMA) and its metabolite, N-methylacetamide (NMA), in urine of workers occupationally exposed to DMA in a factory producing synthetic acrylic fibres.
METHODS: During the first phase, 223 workers exposed to low environmental concentrations of DMA provided urine samples at the end of a work shift. High concentrations of the unmodified solvent and its metabolite were found in a group of workers whose job was to start up machinery. The second and third phases focused on conditions favouring high uptake of DMA.
RESULTS: The highest concentrations of unmodified solvent and NMA were found in the urine of workers recently engaged in starting up machinery. NMA in urine was 1.5-173.6 mg/g creatinine (median 20.5). In spite of the low environmental concentration, about 20% of the urine concentration of NMA was higher than 30 mg/g creatinine. Dermal absorption of DMA was high. A shower and a change of clothing at the end of the work shift, and washing away any solvent left on the skin, ensured that dermal absorption of DMA did not continue. This significantly reduced the NMA urinary concentration at values lower than 30 mg/g creatinine. In some urine samples, S-acetamidomethyl-mercapturic acid was identified by NMR analysis; this is probably a metabolite of N,N-dimethylacetamide--it has never before been identified in humans or animals.
CONCLUSIONS: Even at low environmental concentrations of DMA, dermal absorption can be considerable. Unmodified DMA and NMA concentrations in urine are good biomarkers for monitoring occupational exposure to the solvent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504362      PMCID: PMC1740402          DOI: 10.1136/oem.60.10.746

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  13 in total

1.  Urinary excretion of metabolite following experimental human exposures to DMF or to DMAC.

Authors:  M E Maxfield; J R Barnes; A Azar; H T Trochimowicz
Journal:  J Occup Med       Date:  1975-08

2.  Embryotoxicity in rats and rabbits from cutaneous application of amide-type solvents and substituted ureas.

Authors:  E F Stula; W C Krauss
Journal:  Toxicol Appl Pharmacol       Date:  1977-07       Impact factor: 4.219

Review 3.  Preclinical toxicology and pharmacology of dimethylacetamide, with clinical notes.

Authors:  S N Kim
Journal:  Drug Metab Rev       Date:  1988       Impact factor: 4.518

4.  Dermal absorption of N,N-dimethylacetamide in human volunteers.

Authors:  T Nomiyama; K Omae; C Ishizuka; T Yamauchi; Y Kawasumi; K Yamada; H Endoh; H Sakurai
Journal:  Int Arch Occup Environ Health       Date:  2000-03       Impact factor: 3.015

5.  The urinary concentration of solvents as a biological indicator of exposure: proposal for the biological equivalent exposure limit for nine solvents.

Authors:  S Ghittori; M Imbriani; G Pezzagno; E Capodaglio
Journal:  Am Ind Hyg Assoc J       Date:  1987-09

6.  The metabolism of dimethylformamide and dimethylacetamide.

Authors:  J R Barnes; K E Ranta
Journal:  Toxicol Appl Pharmacol       Date:  1972-10       Impact factor: 4.219

7.  [On occupational pathology caused by dimethylacetmide (with special reference to hepatic function)].

Authors:  G C Corsi
Journal:  Med Lav       Date:  1971-01       Impact factor: 1.275

8.  Biologic monitoring for dimethylacetamide: measurement for 4 consecutive weeks in a workplace.

Authors:  G L Kennedy; J W Pruett
Journal:  J Occup Med       Date:  1989-01

Review 9.  Biological effects of acetamide, formamide, and their monomethyl and dimethyl derivatives.

Authors:  G L Kennedy
Journal:  Crit Rev Toxicol       Date:  1986       Impact factor: 5.635

10.  Chronic toxicity/oncogenicity of dimethylacetamide in rats and mice following inhalation exposure.

Authors:  L A Malley; T W Slone; G T Makovec; G S Elliott; G L Kennedy
Journal:  Fundam Appl Toxicol       Date:  1995-11
View more
  4 in total

1.  Incidence of dimethylacetamide induced hepatic injury among new employees in a cohort of elastane fibre workers.

Authors:  C-Y Lee; S-J Jung; S-A Kim; K-S Park; B-G Ha
Journal:  Occup Environ Med       Date:  2006-05-25       Impact factor: 4.402

Review 2.  Toxic hepatitis in occupational exposure to solvents.

Authors:  Giulia Malaguarnera; Emanuela Cataudella; Maria Giordano; Giuseppe Nunnari; Giuseppe Chisari; Mariano Malaguarnera
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

3.  TNF-α and IL-6 as Biomarkers of Impaired Lung Functions in Dimethylacetamide Exposure.

Authors:  Lütfiye Tutkun; Servet Birgin İritaş; Serdar Deniz; Özgür Öztan; Sedat Abuşoğlu; Ali Ünlü; Vugar Ali Türksoy; Sultan Pınar Çetintepe
Journal:  J Med Biochem       Date:  2019-05-11       Impact factor: 3.402

4.  Concentration determination of urinary metabolites of N,N-dimethylacetamide by high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Shinobu Yamamoto; Akiko Matsumoto; Yuko Yui; Shota Miyazaki; Shinji Kumagai; Hajime Hori; Masayoshi Ichiba
Journal:  J Occup Health       Date:  2017-12-06       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.